Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Hair cortisol may help identify adrenal insufficiency in sickle cell disease patients.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The treatment was effective and tolerable for advanced gastric cancer.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Upadacitinib improved multiple immune-related conditions in one patient.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Sickle cell disease affects BMI and pain frequency, with HbSS patients having more pain and unhealthy BMI.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Tofacitinib can cause a rare rash called SDRIFE, which resolves after stopping the drug.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.